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Two-dimensional (2D) cell cultures have been the primary screening tools to 
predict drug impacts in vitro for decades. However, owing to the lack of tissue-
specific architecture of 2D cultures, secondary screening using three-dimensional 
(3D) cell culture models is often necessary. A microfluidic approach that facilitates 
side-by-side 2D and 3D cell culturing in a single microchannel and thus combines 
the benefits of both set-ups in drug screening; that is, the uniform spatiotemporal 
distributions of oxygen, nutrients, and metabolic wastes in 2D, and the tissue-
like architecture, cell–cell, and cell–extracellular matrix interactions only achieved 
in 3D. The microfluidic platform is made from an organically modified ceramic 
material, which is inherently biocompatible and supports cell adhesion (2D 
culture) and metal adhesion (for integration of impedance electrodes to monitor 
cell proliferation). To induce 3D spheroid formation on another area, a single-step 
lithography process is used to fabricate concave microwells, which are made cell-
repellant by nanofunctionalization (i.e., plasma porosification and hydrophobic 
coating). Thanks to the concave shape of the microwells, the spheroids produced 
on-chip can also be released, with the help of microfluidic flow, for further off-chip 
characterization after culturing. In this study, the methodology is evaluated for 
drug cytotoxicity assessment on human hepatocytes.
than in 2D cell cultures,[1–4] which often 
improves the in vitro–in vivo correlation 
of the drug safety and efficacy assess-
ment.[1,5] For example, significantly 
increased drug resistance (over 2D cell 
cultures) has been reported to cisplatin 
and paclitaxel in 3D spheroid cultures of 
ovarian cancer cell lines[2] as well as to dox-
orubicin in 3D spheroid cultures of breast 
cancer cell lines.[6] For instance, the cyto-
toxicity associated with drug metabolites 
is often underestimated in 2D cultures, 
because the cells grown as monolayers 
seldom express metabolizing enzymes 
at physiological levels and the polariza-
tion of the drug transporter proteins is 
often impaired.[7] 3D cell cultures can be 
established by a variety of techniques, 
including forced floating in hanging drops 
or U-shaped, low-attachment microwell 
plates that promote formation of com-
pact spheroids,[8] as well as by employing 
hydrogels or other matrices that support 
3D architecture for embedded cells.[9] The 
lack of standardization, however, results in some challenges. 
For example, the increasing focal length and consequent light 
scattering are problematic for the detection of large spheroids 
(∅ > 150 µm) and thick matrix specimens, and may necessitate 
the use of clearing agents to improve deep specimen resolu-
tion,[10] which inevitably increases the workload associated with 
3D cultures.
Microfluidics is increasingly exploited to cell culturing in 
both 2D and 3D to better mimic the in vivo conditions in 
drug safety and efficacy assessment.[11–14] By providing precise 
spatiotemporal control over the culture conditions, micro-
fluidics enables improved supply of nutrients and oxygen, 
and efficient removal of metabolic waste. These factors have 
immediate impacts on both the cell health and the accuracy 
of the in vitro-in vivo prediction of drug effects. Addition-
ally, microfabricated cell traps (e.g., microwells) often enable 
production of much smaller 3D cell cultures than achiev-
able for conventional wellplate-based culture platforms. 
This is particularly important to avoid the problems arising 
from diffusion-limited mass transfer, which may impair the 
penetration of antibodies, fluorophores, and other detec-
tion reagents, and thus potentially give rise to false nega-
tive or positive results, in conventional 3D cultures.[10,15,16] 
Most of the commonly used microfabrication methods and 
materials yield vertical walls, that is, cylindrical microwells, 
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1. Introduction
3D in vitro cell culturing techniques have received increased 
recognition in drug screening and validation during the last 
decade. In 3D, the cells retain organ-specific functions better 
© 2020 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, 
Weinheim. This is an open access article under the terms of the Creative 
Commons Attribution License, which permits use, distribution and repro-
duction in any medium, provided the original work is properly cited.
The copyright line for this article was changed on 18 May 2020 after 
original online publication.
Adv. Funct. Mater. 2020, 30, 2000479
www.afm-journal.dewww.advancedsciencenews.com
© 2020 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim2000479 (2 of 11)Adv. Funct. Mater. 2020, 30, 2000479
which sets certain constraints to on-chip spheroid forma-
tion and culturing. In cylindrical microwells, however, the 
cells are initially located far apart from each other and lack 
cell-cell interactions during aggregation, which easily results 
in low reproducibility and high size variation in spheroid for-
mation from well to well. Increasing the initial cell count or 
decreasing the well dimensions improves reproducibility, but 
simultaneously the culturing time becomes limited due to 
the cells outgrowing the wells. Therefore U-shaped wells are 
typically preferred for spheroid culturing. In U-shaped wells, 
the gravitational force is single-pointed, which forces the cells 
closer to each other even if the well size is large (as in con-
ventional U-shaped microtiter plates). Although microfluidic 
flow is relatively easy to integrate with the 2D cell cultures,[13] 
implementation of U-shaped microwells is however signifi-
cantly challenging and may require complex multistep micro-
fabrication protocols.[17] Concave microwells can generally be 
fabricated either directly via, for example, isotropic etching,[18] 
laser ablation,[19] or milling[11] or indirectly by replica-molding 
from an inverse microdroplet-shaped features obtained via, 
for example, photo resist reflow.[20] However, most of these 
processes yield relatively shallow microwells, which cannot 
retain the growing spheroids over extended culturing periods. 
Moreover, most biocompatible polymers lack isotropic etching 
processes and the post-processing possibilities (e.g., metalliza-
tion or spatioselective surface modification) of replica-molded 
microstructures are often limited compared with photolitho-
graphically produced microdevices.
In this paper, we describe a microfabrication method, 
which facilitates straightforward implementation of U-shaped 
microwells for production of small 3D cell spheroids under 
microfluidic flow. The developed microfluidic platform 
is made from an organically modified ceramic material 
(Ormocomp), which is optically transparent down to near-UV 
range[21] and inherently biocompatible supporting cell adhe-
sion without any additional coating.[22–26] Thus, the developed 
platform also enables parallel culturing of 2D cell monolayers, 
under identical growth conditions to those of 3D spheroids, in 
a single microfluidic channel. For the fabrication of the round 
(cross-section profile) microwells, we exploit the controlled 
overexposure of Ormocomp,[27] which facilitates straightfor-
ward customization of the microwell shape and depth in a 
single lithographic step. To further induce 3D spheroid forma-
tion, lithographic (masked) nanofunctionalization by plasma 
processing is exploited to defining local cell-repellant surfaces 
(in the microwell arrays) via porosification and hydrophobic 
coating of the native Ormocomp. Thereby, the developed con-
cept facilitates side-by-side, but isolated culturing of cells in 
2D (monolayers) and 3D (spheroids) on native and modified 
surfaces, respectively, so as to take the best of both worlds. 
Namely, there are certain factors, which favor the use of 2D 
cell culture methodologies in parallel to 3D cultures, such 
as the availability of mature and standardized protocols 
facilitating straightforward detection of localization of target 
proteins within the cells as well as monitoring of cell popu-
lation level events, for example, by impedance spectroscopy 
or fluorescence staining.[5] The concept was herein applied 
to drug cytotoxicity evaluation with the help of paclitaxel, a 
known hepatotoxic anticancer drug.
2. Results and Discussion
2.1. The Concept of Parallel Culturing of Cell Monolayers (2D) 
and Cell Spheroids (3D) on Chip
The microfluidic platform designed herein comprises of 
three arrays of concave microwells that have cell-repellent, 
hydrophobic surface properties (3D cell culture vessels) and 
planar zones of native Ormocomp that supports cell adhe-
sion (2D cell monolayer culturing) (Figure  1 and Figure S1, 
Supporting Information). In addition, the platform comprises 
of two sets of thin-film gold electrodes patterned onto the 
planar, native Ormocomp areas and facilitates monitoring 
of the cell growth and integrity in monolayer cultures by 
impedance spectroscopy. The microfluidic control of growth 
conditions is achieved by sealing the Ormocomp plat-
form with a gas-permeable polydimethylsiloxane (PDMS) 
channel (200 µm × 3 mm × 30 mm, height × width × length) 
(Figure  1a–c). With this setup, the cell loading, seeding, 
flushing of the excess cells, and cell culturing are all per-
formed on-chip sequentially, and most importantly, can be 
done simultaneously for both 2D and 3D cultures (Figure 1c). 
This guarantees that the conditions are exactly the same for 
both culture types.
In this study, the well geometry (depth and shape) was opti-
mized to enable trapping of a large enough population of cells 
to induce cell aggregation, but small enough to leave sufficient 
room for spheroid growth over time (Figure  1d). When using 
the stopped flow approach for cell seeding, the number of 
trapped cells in each microwell was linearly proportional to the 
well size (y =  0.34x-26.58, R2 =  0.9908, Figure  1e). To prevent 
cell adhesion, both inside the wells and around the well array 
(Figure  1f), the Ormocomp surface was made locally hydro-
phobic and nanoporous by plasma treatments, which have 
been shown to reduce cell adhesion in previous literature.[28,29] 
On the untreated, planar areas, the native Ormocomp surface 
supported strong adhesion of both cells (Figure 1f) and metals 
(Figure  1g), which facilitated integration of cell-compatible 
gold electrodes for impedance detection. The cell compatibility 
of native Ormocomp[22–26] as well as the Ormocomp metalliza-
tion protocols[30] has been thoroughly established in previous 
literature. In this study, the impedance spectra were measured 
after cell seeding, once every hour for 96 h, using frequency 
range of 5–100  000  Hz (Figure  1h). The increase in imped-
ance signal at the optimized frequency of 16 kHz was in good 
agreement with the optically observed increase in cell conflu-
ence on top of the gold electrodes (see Figure S2, Supporting 
Information). On the cell monolayer (2D) culture, 80% conflu-
ence was achieved within ca. 48 h (see Figure S2, Supporting 
Information). Critical to the assay performance was also to 
ensure effective isolation of the monolayer and spheroid cul-
tures from each other. In the next section, the validation of the 
microfabrication protocol is described in more detail to illus-
trate how the initial spheroid size can be effectively controlled 
by microfabrication means and how the employed lithographic 
processes enable fabrication of sharp borders between the cell-
adhesive and cell-repellant areas, so that no cells adhere onto 
the porosified, hydrophobic area separating the 2D and 3D 
cultures (Figure 1f).
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Figure 1. The assay set-up for the microfluidic side-by-side 2D and 3D cell culturing device. a) Picture of the chip. b) A diagram of the functional units 
and cross-section cuts across the microchannel at the points of 3D and 2D culturing (cross-cut locations indicated in diagram). c) A cross-section 
cut of the Ormocomp-PDMS-chip along the microchannel with illustrations of the sequential cell seeding steps: 1) cell loading, 2) seeding of cells 
during 30 min under static conditions, and 3) flushing of the excess cells and culturing of the cell monolayers and spheroids under microfluidic flow 
(5.8 mm min−1 for the first 8 h, thereafter 2.3 mm min−1). d) The impact of the nominal microwell diameter (on the photomask) on the resulting 
microwell cross-section profile at constant UV dose of 48 mJ cm−2. Scale bars 20 µm. e) The impact of microwell diameter (nominal) on the number 
of trapped cells (mean ± SD, n > 12 microwells of each size, three independent experiments, 2.5 m cells mL−1). f) The impact of surface modification 
on the cell adhesion illustrating sharp edge of the cell monolayer culture at 96 h. Cell-repellent: hydrophobic and porous. Native: hydrophilic and 
nonporous. g) Cells cultured (48 h) on top of the gold electrodes indicating uniform monolayer formation. h) The on-chip impedance spectra of the 
2D cell culture recorded at 0-48-96 h indicating increased impedance at around 16 kHz as the result of cell proliferation and maturation of the cell–cell 
junctions. The cell stains in (f,g): Hoechst 33342 (blue), Calcein AM (green) and PI (red). Scale bars 100 µm. Illustrations in (b–c) are not in scale.
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2.2. Validation of the Microfabrication Method
The detailed microfabrication process is described in the 
Experimental section and illustrated in Figure S1, Supporting 
Information. Briefly, the depth and cross-section shape of the 
microwells is defined by the UV exposure dose (in a single 
lithographic step), which has been previously applied to 
fabrication of round (cross-section) microchannels for optical 
applications.[27] The evolution of the microwell cross-section 
shape from rectangular to rounded shape upon increasing UV 
dose is illustrated in Figure 2a. After reaching a well-diameter-
dependent threshold dose, the thickness of the residual layer at 
the bottom of the microwell increases linearly as a function of 
UV dose resulting in linearly decreasing microwell depth until 
a saturation level, that is, constant microwell depth, is reached 
(Figure  2b). In addition to depth, the impact of the UV dose 
on the microwell cross-sectional shape was quantified with the 
help of a circle fit to scanning electron micrographs (SEM) in 
Matlab (Figure 2c,d). Generally, lower exposure doses resulted 
in a U-shaped cross-section profile and higher doses in a 
Figure 2. The impact of UV exposure dose on a) the evolution of the microwell shape illustrated in SEM images (scale bars 100 µm), b) the microwell 
height measured by profilometer (mean ± SD, n = 3), arrows pointing the linear area in 200 µm wells, and c) the radius of the curvature determined 
from SEM images (mean ± SD, n = 4) as illustrated in figure (d). e) The impact of plasma porosification on the Ormocomp surface: nonporous (left) 
and porous (right). Scale bars 2 µm. f) The stability of the advancing (θA) and receding (θR) contact angles of native, cell-adhesive (hydrophilic, non-
porous), and treated, cell-repellent (porosified, fluoropolymer coated) Ormocomp surfaces as a function of time (n = 3 measurements each).
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semicircular profile. The required dose was however dependent 
on the microwell diameter (Figure 2a). In this study, an expo-
sure dose of 48  mJ cm−2 was used in all subsequent experi-
ments since it provided rounded cross-sectional profile for the 
largest microwell sizes ranging from 150 to 200 µm in diameter 
(Figures  1d and  2a). Under these conditions, the microwell 
volume and the aspect ratio (w ×  h) could be optimized with 
a view to trapping of desired initial amount of cells during 
seeding and to hold the growing spheroids in the microwells 
over extended periods of time. Most importantly, the lithog-
raphy-based manufacturing of microwells is readily compatible 
with the subsequent lithographic (masked) surface function-
alization, which herein was a combination of oxygen plasma 
porosification similar to Aura et  al.[31] (Figure 2e) and plasma-
enhanced chemical vapor deposition of fluoropolymer. Since 
both surface modifications were applied in a single lithography 
step, they were perfectly aligned with each other facilitating 
a clear change in the surface wettability compared with the 
native Ormocomp surface. As the result of the treatments, the 
advancing water contact angle increased from 69 ±  1° (native) 
to 112 ± 2° (modified), and the altered surface properties were 
shown to be stable over at least one month (Figure 2f). However, 
the surface treatments did not significantly affect the receding 
contact angle (native 28  ±  1° versus modified 27  ±  1°), indi-
cating that some hydrophilic moieties were left on the modified 
surfaces as well. Altogether, these properties resulted in 
effective cell repellence on the modified surfaces.
2.3. Characterization of the 3D Spheroid Formation on Chip
The feasibility of the developed Ormocomp chip for culturing 
of 3D cell spheroids was examined with human hepatocytes 
seeded into the hybrid Ormocomp-PDMS channel (Huh7, 
2.5 m mL−1 in complete growth medium). In these experiments, 
three arrays of 4 × 10 microwells, each featuring different, but 
constant (within array) microwell diameters, that is, 150, 175, 
and 200 µm, were incorporated into a single microchannel. The 
hydrophobic and nanoporous surface (in the microwell area) 
was able to resist cell adhesion for at least 30 min, which was 
the duration of the static cell seeding step in this study and suf-
ficient to ensure strong enough cell adhesion onto native Ormo-
comp areas and cell sedimentation into the microwells. After 
cell seeding, a flow of complete medium, supplemented with 
2% (v/v) Geltrex to provide with soluble extra cellular matrix 
(ECM) components, was applied at a flow rate of 5.8 mm min−1 
(0.033  dyne cm−2) for the first 8  h to ensure removal of 
unadhered cells from the channel. Thereafter, the cell cul-
ture was maintained under constant flow of 2.3  mm min−1 
(0.012 dyne cm−2). The spheroid growth over time (3D culture) 
is illustrated in Figure 3a,b. In the 150 µm (nominal i.d.) micro-
wells, the lift force induced by the microfluidic flow resulted 
in premature release of the outgrowing spheroids, but in the 
175 and 200 µm (i.d.) microwells, the spheroid size was shown 
to increase linearly over time for at least 96  h (Figure  3b). 
Besides culturing time, the spheroid size was dependent on 
the microwell diameter, that is, the initial number of trapped 
cells (Figure 1e). As expected, the initial cell number required to 
produce compact spheroids within 24 h was substantially lower 
compared with previous work employing cylindrical microwells 
(flat bottom, vertical sidewalls, e.g., Patra et al.[12]).
In addition to spheroid formation, the round (cross-section) 
microwell shape was critical to facilitating controlled release of 
the on-chip cultured spheroids for further off-chip characteri-
zation, which is not as easily achieved when using cylindrical 
microwells. The fact that most microfluidic 3D cell cultures 
only enable on-chip (in situ) cell analysis, and thus, omit the 
possibility to use the state-of-the-art “off-chip” cell characte-
rion techniques (e.g., flow cytometry, light sheet microscopy, 
or optical projection tomography) is currently one of the major 
hurdles of microfluidic 3D cell culturing. Detailed characteriza-
tion of the 3D shape and size of the formed spheroids is par-
ticularly important when introducing new cell lines, because of 
reported differences in spheroid formation between different 
cell types.[8] In this study, the shape and size of the on-chip cul-
tured hepatocyte spheroids were determined in more detail by 
light sheet microscopy (off-chip analysis) to supplement the in 
situ characterization by optical microscopy. For this purpose, 
new microfluidic designs incorporating only one size of micro-
wells per each channel were fabricated to enable culturing of 
batches of uniform spheroids. This design incorporated total of 
340 microwells (ca. 19  wells mm−2). After day 4, the spheroid 
size typically exceeded the threshold value for retention (e.g., 
ca. 160 µm spheroid size in ∅ 200 µm microwells), which facili-
tated easy release of the spheroids from the concave micro wells 
with the help of the lift force induced by the fluid flow. The 
light sheet microscopy confirmed that the spheroids formed 
in the Ormocomp microwells were symmetrical (sphericity of 
0.97  ±  0.01, Figure  3d) and exhibited organized cellular hier-
archy with cortically localized filamentous actin (Figure  3e). 
These results thereby evidenced that the spheroid architechture 
was truly 3D and qualified the use of the spheroid diameter 
(determined in situ based on optical microscopy) as a repre-
sentative measure of the spheroid growth in further method 
validation studies.
2.4. Method Validation for Drug Cytotoxicity Screening
The impact of drug exposure on the parallel 2D and 3D hepato-
cyte cultures was examined with the help of a known hepato-
toxic anticancer drug, paclitaxel. Paclitaxel is known to cause 
cell cycle arrest into the G2/M phase by binding to β-tubulin, 
which leads to kinetic stabilization of mitotic spindle micro-
tubule dynamics, and further, to deformation of nuclei and 
growth arrest.[32] Also in the control experiments (2D cell 
cultures on microtiter plates) performed in this study, pacli-
taxel was shown to cause a time- and dose-dependent cell cycle 
arrest (Figure 4a and Figure S3, Supporting Information). On 
the microfluidic platform, the impact of paclitaxel exposure 
on the 3D spheroid growth was assessed based on spheroid 
diameter (in situ determination by optical microscopy), and 
on the cell monolayer (2D) integrity based on on-chip imped-
ance spectroscopy. As a result of paclitaxel exposure (100 and 
1000  nm), a clear dose-dependent inhibition of the 2D and 
3D cell growth was detected in the on-chip impedance signal 
(Figure  4b) and in the spheroid size (Figure  4c, Tables S1,S2, 
Supporting Information), respectively. In both cases, the high 
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Figure 3. Characterization of Huh7 spheroids grown in concave microwells in Ormocomp channel under flow conditions. a) Spheroid growth in 
200 µm wells over time (48-72-96 h). b) Linear growth of spheroids in both 175 and 200 µm wells over time (R2 = 0.9885 and 0.967 for 175 and 200 µm 
well, respectively, mean ± SD, n > 12, three independent experiments). c) Correlation of spheroid volumes and number of nuclei (Pearson’s correla-
tion 0.951, p < 0.01) analyzed using light sheet microscope Z-stack images and IMARIS analysis software. d) 3D construct of merged channels (actin, 
green; and nuclei, red) (top), analysis of nuclei surfaces (middle), and surface of the whole spheroid volume (bottom). e) Inner spheroid structural 
details of the actin and nuclei alignment from selected Z-heights indicated in diagram. (c,d) The 3D constructs created from 0.47 µm thick Z-stack 
images. a,d,e) Scale bars 50 µm.
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Figure 4. Validation of parallel cell culturing set-ups. a) Paclitaxel induced, time-dependent cell cycle arrest in G2/M-phase in Huh7 cells in a 2D cell 
culture on the standard 96-well plate, and in 3D spheroids cultured on-chip. The data represents the mean ± SD from n = 3 repeated experiments. 
b) Disruption of the cell monolayer integrity (2D) observed on the on-chip impedance sensor at 16 kHz. The impedance signal was normalized to the 
signal obtained two hours (t = −2 h) before dosing the drug (t = 0 h). Baseline impedance values at time 0 h (the time of dosing the drug) were 2108 Ω 
for control (medium) and 1366 and 1458 Ω for cell monolayers exposed to 100 and 1000 nm paclitaxel, respectively. c) The effect of paclitaxel on spheroid 
size. Paclitaxel was introduced at 48 h (0 h post-exposure) and drug effects were evaluated at 20 or 48 h post-exposure (mean ± SD). Number of char-
acteristic measures (two characteristic measures of diameter/spheroid): n0 h, control = 62, n20 h, control = 60, n20 h, paclitaxel 100 nm = 68, n20 h, paclitaxel 1000 nm =  
68, n48 h, control = 73, n48 h, paclitaxel 50 nm = 307. Pair-wise comparison of independent samples based on Kruskal–Wallis test. p < 0.05 was considered to 
be statistically significant difference, and also the limits of **p < 0.01 and ***p < 0.001 were evaluated. n.s. = non-significant. d) Orthogonal projec-
tions of a control spheroid, not exposed to paclitaxel (left) and spheroid exposed to high dose (500 nm) of paclitaxel for 48 h (right) corresponding 
total culturing time of 96 h. Spheroids were fluorescent-labeled for F-actin (Actin-Green, green) and nuclei (DRAQ-5, red). Scale bars 50 µm.
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paclitaxel dose (1000  nm) terminated the cell proliferation 
instantly. The post-exposure size of the spheroids in the pres-
ence of 1000 nm paclitaxel at 20 h (i.e., after one post-exposure 
cell cycle) was 99 ±  14 µm (n =  34), which was similar to that 
before the exposure (104 ± 8 µm, n = 31) indicating immediate 
termination of the cell proliferation (Figure  4c). The cell cycle 
arrest was further confirmed by off-chip cytometric analysis 
of the propidium iodide (PI) stained cells (dissociated sphe-
roids). When exposed to 1000  nm paclitaxel the proportion of 
spheroid cells in G2/M phase (74.6 ±  10.3%) was comparable 
to the value (90.2 ±  0.8%) obtained from the conventional 2D 
culture (Figure  4a). Instead, when exposed to a lower dose of 
paclitaxel, the spheroids continued to grow, and the impact of 
paclitaxel could not be seen yet after 20 h exposure period. After 
the first 20 h of paclitaxel exposure (100 nm), the spheroid size 
(118 ± 12 µm, n = 34) did not significantly differ from that of the 
control (114 ± 14 µm, n = 30) (Figure 4c). In the 2D culture, how-
ever, the lower paclitaxel dose (100 nm) retarded the cell growth 
in a time-dependent manner with lag time of ca. 8 h compared 
with the high dose (1000 nm) suggesting that some of the cells 
continue to proliferate even upon paclitaxel exposure if the 
dose is sufficiently low (time-dependent cell-cycle arrest). This 
observation is well in line with the previous literature, which 
describes a time-dependent inhibition of cell proliferation at 
notably low concentrations as a result of paclitaxel accumula-
tion in cells. For example, the IC50 value of paclitaxel in HeLa 
cells is ca. 8  nm only.[32] To further evaluate the feasibility of 
the developed platform for detection of such time-dependent 
drug impacts, the 3D spheroid culture was exposed to 50  nm 
paclitaxel concentration, which was well below the threshold 
of acute cytotoxicity on the basis of the afore-mentioned short-
exposure experiments with microfluidic 3D and 2D cultures. 
To ensure sufficiently good signal window (here, the Z′ factor 
was 0.8), exposure time of 48 h was used to assess the impact 
of paclitaxel at lower doses. Under these conditions, the post-
exposure (50 nm paclitaxel, 48 h) spheroid size was 118 ± 14 µm 
(n =  153), which corresponds to ca. 27% of the growth of the 
control spheroids (161  ±  20 µm, n  =  36) grown for the same 
period of time (total of 96 h) (Figure 4c). Besides spheroid size, 
the cell viability was assessed in situ using the standard fluo-
rescent stains for viable (calcein AM) and dead (PI) cells after 
96 h of culturing (control spheroids) or 48 h culturing and 48 h 
paclitaxel exposure (Figure S4, Supporting Information). By 
releasing the spheroids, deformation of the nuclei and growth 
arrest could also be confirmed by off-chip light sheet micros-
copy. A clear change in the spheroid size, shape, and nuclei 
morphology was observed compared with control spheroids not 
exposed to paclitaxel (Figure 4d).
3. Conclusion
In this study, we took advantage of the beneficial properties 
of the commercial organic-inorganic hybrid polymer, Ormo-
comp, to set up and validate first in its kind microfluidic 
platform for simultaneous culturing of 2D cell monolayers 
and 3D cell spheroids. On one hand, the possibility to create 
rounded microstructures in a single lithographic step, together 
with subsequent lithography-based cell-repellant surface 
functionalization, provides substantial progress toward facile 
microfabrication of U-shaped microwells for 3D cell spheroid 
culturing under microfluidic flow. Utmost critical from the per-
spective of drug screening is the possibility to culture small, 
uniform spheroids in a reproducible manner and to release 
the spheroids for further off-chip analysis after drug exposure. 
Compared with in situ fluorescent staining, this diversifies the 
selection of end-points by facilitating closer examination of 
the spheroids by state-of-the-art off-chip cell characterization 
techniques and algorithm-based image analysis. On the other 
hand, the inherent surface properties of native Ormocomp 
support strong adhesion of cells and metals, which facilitates 
implementation of 2D cell monolayer cultures, and their non-
invasive monitoring with the help of impedance spectroscopy 
(via integrated electrodes), on unmodified, planar parts of the 
same microchannel. Altogether, these technical achievements 
enable comprehensive evaluation of both immediate and time-
dependent drug impacts on cellular events in both 2D and 3D, 
as shown with the help of paclitaxel in this study.
Although this work mainly focuses on performance character-
ization and proof-of-concept validation of the assay design (using 
relatively simple biological model and only a single microchannel 
at a time), the same microfabrication protocol is readily feasible 
for wafer-scale manufacturing of multiple, parallelly actuated 
microchannels of the same type. This is particularly important 
with a view to increasing the somewhat low throughput of the 
current assay design (only one exposure test per device) toward 
higher throughput screening of new drug candidates. More-
over, the microfabrication concept presented herein, provides a 
straightforward approach to upscaling of the number of micro-
wells for high quantity spheroid culturing under identical flow 
conditions. In the present design, the microwell density was ca. 
19 wells per mm2 (for d =  200 µm well size and 30 µm well-
to-well spacing), which easily outnumbers the regular wellplate 
set-ups in terms of spheroid production for characterization pur-
poses. For many state-of-the-art cell characterization techniques, 
the number of cells needs to be much higher than that of a 
single spheroid. Thus, the approach presented herein, that is, 
culturing of multiple small spheroids under identical conditions 
followed by off-chip cell characterization by multiple different 
techniques, is capable of combining the best of both worlds 
(microfluidics and conventional 3D cell culturing). Despite the 
relatively low throughput and limited biological complexity of 
the current assay design, the wealth of cell-level information that 
can be derived from different end-point measurements (in 2D 
and 3D) is likely to provide a more comprehensive and accurate 
in vitro prediction of the in vivo drug impacts compared with 
current state-of-the-art cell culture methodologies.
4. Experimental Section
Microfabrication Methods and Materials: The microfluidic platforms 
(Figure S1, Supporting Information) were fabricated out of Ormocomp, 
a commercially available formulation of organically modified ceramics 
(Microresist Tehcnology, GmbH, Berlin, Germany), metallized 
using thin-film techniques, and sealed with an oxygen-permeable 
polydimethylsiloxane channel (PDMS, Sylgard 184, Dow Chemicals, 
Midland, MI). The full microfabrication process is illustrated in 
Figure S1, Supporting Information and elaborated below.
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Defining the Microwells Out of Ormocomp for 3D Cell Spheroid 
Culturing: Ormocomp was spincoated and UV-cured (MA-6 mask 
aligner, SÜS MicroTec Inc., Garching, Germany) on 350 µm-thick Pyrex 
glass wafers (Plan Optik, AG, Elsoff, Germany) dehydrated in the oven 
(120  °C, 1  h). The first layer of Ormocomp (spin coated 6000  rpm, 
30 s) was flood exposed (constant UV dose of 76 mJ cm−2) and baked 
in the oven post-exposure (90  °C, 30 min) to yield a 15 µm-thick base 
layer (Figure S1A, Supporting Information). Next, the second layer of 
Ormocomp (800  rpm, 15  s) was UV exposed through a photomask 
in proximity mode (gap distance 450 µm) and baked (90  °C, 30  min) 
to define the microwells (Figure S1B, Supporting Information). The 
microwell diameter was controlled by the photomask (nominal well 
dimensions 125, 150, 175, and 200 µm) and the depth was controlled 
by the UV exposure dose (ranging between 13 and 48  mJ cm−2), as 
illustrated in Figure 2. Finally, the Ormocomp structures were developed 
in OrmoDev (Microresist Technology GmbH) for 5  min, rinsed 
with isopropanol, dried, and hardbaked on a hotplate (200  °C, 2  h) 
(Figure S1C, Supporting Information). The final microdevice comprised 
three arrays (ca. 3.58 × 2 mm2 cell-repellent area) of 4 ×  10 microwells 
with 30 µm inter-well spacing.
Defining the Thin-Film Electrodes for Monitoring Cell Monolayer (2D) 
Integrity: For noninvasive monitoring of cell monolayer growth based 
on electrical impedance sensing, two pairs of thin-film gold electrodes 
were implemented onto the planar Ormocomp surfaces between the 
microwell arrays (Figure  1a). First, a 10 nm-thick titanium layer was 
deposited over the entire wafer by evaporation (IM-9912 evaporator, 
Instrumentti Mattila, Mynämäki, Finland) under same condition 
which pointed in Bonabi et  al.[30] to promote gold adhesion onto the 
Ormocomp substrate (Figure S1D, Supporting Information). Next, 
a 100 nm-thick gold layer was deposited by evaporation (Figure S1E, 
Supporting Information) and patterned by photolithography. The metal 
pellets for evaporation (Ti and Au) were purchased from Kurt J. Lesker 
Company Ltd. (East Sussex, UK) and all were of 99.99–99.999% purity. 
A hexamethyldisilazane was applied by chemical vapor deposition 
(30  min) at 150  °C in the oven (Yield Engineering System, Livermore, 
California, USA) on top of the metallized surface to promote adhesion of 
the photoresist. Next, a 10 µm-thick layer of a positive tone photoresist, 
AZ4562 (MicroChemicals GmbH, Ulm, Germany), was spincoated 
(2000  rpm, 30 s) onto the metallized surface (Figure S1F, Supporting 
Information), softbaked on a hotplate (100  °C, 50  s), and patterned 
by masked UV exposure (570  mJ cm−2) using the MA-6 mask aligner 
(Figure S1G, Supporting Information) and developed in AZ826F 
MIF developer (MicroChemicals GmbH, Ulm, Germany) for 3  min 
(Figure S1H, Supporting Information). To ensure complete removal of 
the photoresist also in the deep microwells, the masked UV exposure 
(380  mJ cm−2) and development (3  min) was repeated for the second 
time. Afterwards, the resist was hardbaked on a hotplate (115 °C, 50 s). 
The nominal dimensions of the photoresist (masked) pattern comprised 
of two identical, semi-circular (r  =  1000  µm) working and reference 
electrodes opposing each other, located within the microchannel, and 
connected through 100 µm-wide wires with contact pads (30 × 30 mm2) 
residing at the sides of the chip (Figure S1, Supporting Information). 
This pattern was then transferred to the metal layer by sequential etching 
of gold in aqua regia (a mixture of 69% nitric acid and 37% hydrochloric 
acid, 1:3, v/v) (35  °C, 10  s) (Figure S1I, Supporting Information) and 
Ti in a mixture of deionized water, hydrogen peroxide and ammonium 
hydroxide (Honeywell, North Carolina, USA) (12:1.8:1, v/v, RT, 5  min) 
(Figure S1J, Supporting Information). Finally, the impedance electrodes 
were revealed upon resist removal (lift-off) in AZ100 remover (Microresist 
Technology GmbH, Berlin, Germany) (RT, 10  min) (Figure S1K, 
Supporting Information). The electrical resistivity of the impedance 
electrodes was determined by measuring the sheet resistance (RS) 
of the metallization with a 4-point probe (CPS probe station, Keithley 
2000 multimeter, Cascade Microtech) after metal deposition but before 
patterning. The average value (319 ±  3 mΩ) from three measurements 
was then used for calculation of the bulk resistivity (ρ).
Modification of the Surface Properties to Control Cell Adherence: The 
inherently cell-adhesive Ormocomp surface was locally modified by 
oxygen plasma treatment and hydropolymer coating to create cell-
repellant porous and hydrophobic surface, respectively, around the 
microwell arrays (Figure S1, Supporting Information). First, the cell-
repellant areas (3.58  ×  2  mm2) was defined by photolithography. 
Briefly, a 12 µm-thick layer of the AZ4562 photoresist was spincoated 
(1500 rpm, 30 s) over the entire wafer, softbaked (Figure S1L, Supporting 
Information), patterned by masked UV exposure (twice) (Figure S1M, 
Supporting Information), and developed and hardbaked following 
protocol similar to electrode patterning (Figure S1N, Supporting 
Information). Only in this case, the cell-repellant areas were left 
unpatterned and all other areas, including the metallizations, were 
protected by the photoresist. To create the pores on the cell-repellant 
areas, the wafer was treated with oxygen plasma by reactive ion etching 
(200  W, 250  mTorr, O2 flow 45  sccm, argon flow 5  sccm) for 20  min 
using Plasmalab 80+ (Oxford Instruments, Bristol, UK). Prior to plasma 
treatment, the chamber was cleaned with SF6 + O2 plasma for 30 min. 
Then, a hydrophobic fluoropolymer coating was deposited by plasma-
enhanced chemical vapor deposition (50  W, 250  mTorr, CHF3 flow 
100 sccm, 5 min, Plasmalab 80+) (Figure S1O, Supporting Information) 
followed by resist removal (lift-off) in AZ 100 remover (RT, 20 min) and 
sequential rinsing with isopropanol and water (Figure S1P, Supporting 
Information).
Sealing with Polydimethylsiloxane Lid: After metallization and surface 
treatment, the microwell arrays and the planar, native areas with 
impedance electrodes were sealed with a polydimethylsiloxane (PDMS) 
channel (3 ×  0.2 ×  30 mm3, w ×  h ×  L). The master was fabricated by 
spincoating SU-8 100 photoresist (Microchem Corporation, Newton, 
MA) on a silicon wafer (1700 rpm, 30 s) to obtain a 200 µm-thick layer. 
The softbake of SU-8 was done by using a slow ramp function first from 
RT to +65  °C and kept at +65  °C for 25  min, and then from +65  °C 
to +95  °C and kept at +95  °C for 3.5  h before gradual cooling to RT. 
Following softbake, the microchannels were patterned by UV exposure 
(65 s) on a mask aligner (SÜSMicroTec Inc.) after which the wafer was 
hardbaked by using a slow ramp function first from RT +65 °C and kept 
at +65 °C for 80 min and then gradually cooling to RT. Next it developed 
in mr-Dev 600 (Microresist technology Inc.) for 1 h. Last, the wafer was 
rinsed with isopropanol and dried. Finally, a fluoropolymer coating 
(CHF3, 100 sccm, 50 W, 250 mTorr, 10 min) was applied using PECVD 
(Plasmalab 80 Plus, Oxford Instruments Inc.) to act as an anti-adhesion 
layer.
Next, PDMS prepolymer and curing agent were mixed in a ratio of 
15:1 (m/m), poured on top of the SU-8 master to reach ca. 5 mm-thick 
layer and degassed by placing the master in the desiccator for 1  h. 
To ensure good bonding strength between PDMS channel and the 
Ormocomp surface, PDMS was only partially cured (75  °C, 40  min) 
and plasma oxidized (60  W, O2 flux 500  mL min−1, 60  s, PS 400, PVA 
TePla, Wettenberg, Germany) prior to bonding (Figure S1Q, Supporting 
Information). The inlet and outlet holes were also pierced to PDMS 
and the Ormocomp bottom parts diced to appropriate size (DAD 3220, 
Disco, Tokyo, Japan) before bonding. Finally, the crosslinking of the 
bonded PDMS channel was completed by applying 500 gram to 1  kg 
weight bar on PDMS with overnight cure in the oven at 80 °C (Figure S1R, 
Supporting Information).
Characterization of Ormocomp Microstructures: Analysis of Microwell 
Size and Shape: Microwell height (n  =  3 wells of each type) was 
determined with profilometer (Dektak XT, Bruker Inc, Karlsruhe, 
Germany) with 15 mg stylus force and scan resolution of 0.02 µm.
The effect of exposure dose on the microwells cross-section shape 
was determined from four parallel samples of each type by using 
scanning electron microscopy (SEM EBL Zeiss Supra 40). Before SEM 
analysis, all samples were sputtered by 20  nm Au (Bal-Tec SCD 050, 
Schalksmühle, Germany) and diced with the dicing saw to obtain cross 
sections. The SEM images were analyzed with Matlab to determine the 
radius of curvature (r), residual thickness, and height of the microwells 
cross-sections. The height and residual thickness determinations were a 
complementary method to confirm profilometer data.
Characterization of Ormocomp Microstructures: Analysis of Surface 
Treatment: The stability of the surface treatment over time was examined 
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by contact angle goniometry using the sessile droplet needle method 
(Theta, Biolin Scientific, Espoo, Finland). The advancing contact angles 
were measured from 1 to 7 µL, and the receding from 7 to 0 µL. The 
droplet rate was 0.1 µL s−1. A clear difference between both advancing 
and receding contact angles were observed between native and treated 
surfaces and the observed change was also stable over time (Figure 2e).
Cell Maintenance: Huh7 human hepatoma cells (a kind gift from 
Dr. Moshe Finel, University of Helsinki, Finland) used in this study were 
maintained in complete growth medium consisting of high-glucose 
DMEM medium (Sigma, Saint Louis, MO) supplemented with 10% fetal 
bovine serum (Gibco, Paisley, UK), 1% non-essential amino acids (Gibco, 
Paisley, UK), 10 000 U mL−1 penicillin, and 10 000 µg mL−1 streptomycin 
(Gibco, Grand Island, NY, USA) in standard culture conditions (+37 °C, 
5% CO2, 95% humidity), and sub-cultured when reaching <  90% of 
confluence.
Cell Seeding to the Microchannel: Before cell seeding, the bonded 
microdevice was flushed first with 70% (v/v) ethanol (aq) (with at least 
10× the channel volume) and then with complete growth medium. The 
ethanol rinse also improved the wetting of the channels thus avoiding 
air bubbles from trapping into the hydrophobic microwells. Next, the 
cells (2.5 m mL−1) were loaded into the channel and allowed to adhere 
on native, planar Ormocomp or to sediment in microwells for 30 min, 
after which the flow was initiated. The flow rate used was 3.5 µL min−1 
(5.8 mm min−1) for the first 8 h, thereafter 1.4 µL min−1 (2.3 mm min−1). 
The growth medium consisted of the complete medium supplemented 
with 2% (v/v) Geltrex (Geltrex LDEV-Free Reduced Growth Factor 
Basement Membrane Matrix, Gibco, Grand Island, NY), to promote 
spheroid formation in the microwells as it provides with the ECM 
components to 3D cultures.
On-Chip Imaging: During incubation spheroid growth was monitored 
online using Cytosmart camera and Cytosmart Lux2 software (Incyte, 
the Netherlands). At chosen end points (24, 48, 72, and 96  h), the 
microdevices were removed from the incubator, and the cells were 
imaged, and stained using Calcein AM (1  µm, Invitrogen, Eugene, 
OR), PI (2  drops per mL, ReadyProbes Reagent, Invitrogen, Eugene, 
OR), and Hoechst 33 342 (2 drops per mL, NucBlue Live ReadyProbes 
Reagent, Invitrogen, Eugene, OR) for live cells, dead cells, and all 
nuclei, respectively. The cells were imaged using either AxioVert A1 FL 
epifluorescence microscope (Zeiss Finland, Espoo, Finland) equipped 
with a broadband lamp (Illuminator HXP 120  V, Leistungselektronik 
JENA GmbH, Jena, Germany) and Axiocam 305 microscope camera 
(Zeiss Finland, Espoo, Finland), or AxioScope A1 epifluorescence upright 
microscope (Zeiss Finland, Espoo, Finland) equipped with halogen 
broadband lamp (HAL 100, Zeiss) and Retiga 4000R CCD camera (Q 
Imaging, Surrey, BC, Canada). All images were analyzed with ImageJ 
freeware.
On-Chip Impedance Spectroscopy: The cell monolayer growth was 
monitored with help of impedance spectra recorded once every hour 
(44 data points between 5–100 000 Hz, UAC =  10 mV) using PalmSens4 
potentiostat (PalmSens BV, Houten, the Netherlands). Impedance of cell 
covered electrode versus cell-free electrode were extracted from the data, 
and maximum signal was detected at frequency of 16 kHz, thus this was 
considered the optimal frequency[33] to monitor the hepatocyte monolayer 
integrity upon cell culturing and drug exposure in this particular system.
Flow Cytometric Analysis: Cell cycle analysis was assessed with help 
of flow cytometry. For the flow cytometric analyses spheroids chips 
with 4 × 85 well arrays with a single well diameter (all d = 200 µm with 
30 µm inter-well spacing, comprised of no planar areas) were used to 
ensure >10 000 events for the analysis. The cell count resulting from the 
on-chip cell monolayer cultures was not high enough for flow cytometry 
analysis, and thus, the drug effects on cell monolayer cultures were 
assessed on the basis of conventional microtiter plate cultures. For flow 
cytometric analysis, the spheroids were flushed out of the microchannel 
and dissociated with Accutase (Invitrogen, Carlsbad, CA). Dissociation 
of spheroids into a homogenous cell suspension was achieved upon 
20–30  min incubation at +37  °C aided by brief mixing with a pipette 
every 10  min. After dissociation, the cells were washed and fixed with 
ice-cold 70% (v/v) ethanol (aq) over night. For cell cycle analysis, the 
cells were stained with FxCycle RNase/PI staining solution (Invitrogen, 
Eugene, OR) according to the manufacturer’s instruction, and analyzed 
with BD Accuri Flow Cytometer (BD bioscience, Franklin Lakes, New 
Jersey). Monolayer cells were dissociated for 10 min using Accutace, and 
onwards, handled similarly to dissociated spheroid cells. FloJo software 
(FloJo LLC, Ashland, Oregon) was used for data analysis.
Light Sheet Microscopy: Detailed analysis of spheroid structures was 
done off-chip using a Zeiss Light Sheet Z.1 microscope (Zeiss) with 
filter set of BP505-545 LP660 404900–9318 and 20×/1.0 dipping water 
objective. Spheroids smaller than 100 µm in diameter were flushed off-
chip, fixed in 4% paraformaldehyde (PFA) for 15  min, following with 
permeabilization in 0.5% Triton-X 100 for 15 min (RT), and blocking in 
3% bovine serum albumin (fraction V, de-lipidated, New Zealand source 
in DPBS) (Image-iT Fixation/Permeabilization Kit, Invitrogen, Grand 
Island, NY). Spheroids larger than 100 µm in diameter were flushed off-
chip, fixed and permeabilized simultaneously in a mixture of 2% PFA and 
0.25% (v/v) Triton-X 100 for 3 h (RT). Actin was stained using ActinGreen 
488 ReadyProbes Reagent (Invitrogen, Eugene, OR) and nuclei with 
10 µm DRAQ-5 (Thermo Scientific, England, Scotland, UK) over night 
(+4  °C). The spheroids were mounted in TopVision low-melting point 
agarose (Thermo Scientific) and imaged in phosphate-buffered saline. 
Every spheroid was imaged using 0.47 µm stack heights and dual side 
illumination. Image analysis was done with IMARIS 9.2.1. software.
Statistics: Data are expressed as mean ± SD, as is also indicated in 
the figure legends. Linear regression or Pearson’s correlation (two-tailed, 
data normality tested with Shapiro–Wilk) were used in the validation 
studies (Figures  3b,c, respectively). Drug impact on spheroid size was 
compared pair-wise as independent samples using the Kruskal–Wallis 
test (asymptotic significances, 2-tailed tests, significance values were 
adjusted by the Bonferroni correction for multiple tests) (Figure  4c). 
Data in Figure  4c are presented as box-and-whisker plots in which the 
boxes indicate the first and third quartiles with median, the upper and 
lower bars minimum and maximum values, and the circles outliers. 
Statistical analysis was done with IBM SPSS statistics 25.
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